相关实验视频
Updated: Jan 29, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.4K
基于纳米体的生物结合物作为艾滋病毒进入的强大和广泛活性抑制剂
Shubhra Jyoti Saha1, Rashmi Kumariya1, Phoenix A Davis1
1Laboratory of Bioorganic Chemistry; National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
Journal of the American Chemical Society
|January 27, 2026
概括
科学家们开发了一种新的半合成方法来制造强效的抗艾滋病毒药物. 这种方法将化学合成与抗体碎片结合在一起,从而显著改善了针对各种HIV菌株的抗病毒活性.
科学领域:
- 生物结合化学 生物结合化学
- 病毒学 病毒学
- 蛋白质工程是指蛋白质工程.
背景情况:
- 开发有效的HIV-1疗法仍然是一个关键的挑战.
- 目前的治疗方法在效力和抗药性发展方面存在局限性.
- 通过融合抑制剂准病毒进入提供了一个有前途的治疗策略.
研究的目的:
- 开发一种新的半合成策略,用于制造强效的抗艾滋病毒药物.
- 结合化学合成和抗体碎片的优势,增强抗病毒活性.
- 探索融合抑制剂和纳米体的新连接策略.
主要方法:
- 使用选择性酶结合和点击化学用于结合组装.
- 创建的纳米体融合抑制 (Nb-FI) 结合物将合成与纳米体连接起来.
- 探索了用于各种连接几何形状的模块化组件,包括新的C-to-C拓.
主要成果:
- 与单独的酸相比,半合成合物在抗病毒功效方面表现出高达1万倍的改善.
- 实现了针对各种HIV-1菌株的广谱活性.
- 在抗病毒疗效方面表现优于类似的基因融合结构.
结论:
- 半合成方法为开发高效抗艾滋病毒疗法提供了一个多功能平台.
- 结合化学合成和抗体工程,利用近距离效应进行有效的病毒阻断.
- 这一策略有望克服HIV-1耐药性并改善治疗结果.
相关概念视频
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Acid–Base Equilibria: Activity-Based Definition of pH
1.3K
For an ideal solution, the pH is defined as the negative logarithm of the hydrogen ion concentration. For a non-ideal solution, an accurate measurement of the pH must consider the negative logarithm of the hydrogen ion activity rather than concentration. In such a solution, the pH can be more accurately defined as the negative logarithm of a product of the hydrogen ion concentration and its activity coefficient.
In solutions of very low ionic strength—for example, pure water—the...
In solutions of very low ionic strength—for example, pure water—the...
1.3K
Dipeptidyl Peptidase 4 Inhibitors
644
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
644
Antihypertensive Drugs: Direct Renin Inhibitors
1.5K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.5K
tRNA Activation
22.9K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.5K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.5K

